Schedule 13D ownership disclosure

OWC Pharmaceutical Research Corp.

Security class unavailable · CUSIP: 67109N108

Event date: 2020-03-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
44,175,000
Percent of class
14.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001811451-20-000005
Form type
SC 13D
Filer
Sunbeam Management, LLC
CIK
CIK 1811451
Filed
May 21, 2020
Reporting period
Mar 23, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub